Skip to content
Colorectal Cancer Clinical Trials

Texas

Colorectal cancer clinical trials in Texas

195 colorectal cancer studies are recruiting participants at sites in 43 cities across Texas as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Browse Texas by city

Cities with the most studies recruiting right now.

Every Texas city with a recruiting study

Houston (140), San Antonio (53), Dallas (46), Austin (22), Irving (16), Fort Worth (9), Tyler (9), Temple (7), Abilene (5), Amarillo (4), Round Rock (3), Sugar Land (3), Webster (3), Beaumont (2), Bedford (2), Conroe (2), Denison (2), Denton (2), Edinburg (2), El Paso (2), Forth Worth (2), Kingwood (2), Laredo (2), League City (2), Pearland (2), Richardson (2), The Woodlands (2), Arlington (1), Austin, TX 78758 (1), Flower Mound (1), Galveston (1), Garland (1), Grapevine (1), Humble (1), Longview (1), Midland (1), Odessa (1), Paris (1), Plano (1), Shenandoah (1), Texas City (1), Tomball (1), Wichita Falls (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Texas

Basic details from each study's public record (the 12 most recently updated of 195). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    ECOG-ACRIN Cancer Research Group
    Recruiting in
    Dallas · Fort Worth · Richardson
    Registry record
    NCT05863195 · updated
  2. Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Boehringer Ingelheim
    Recruiting in
    Houston
    Registry record
    NCT06324357 · updated
  3. A Study of TSN1611 Treating Patients With Advanced Solid Tumors Harboring KRAS G12D Mutation

    • Phase 1/2
    • Ages 18 to 75
    • All sexes
    Sponsor
    Tyligand Pharmaceuticals (Suzhou) Limited
    Recruiting in
    Houston · San Antonio
    Registry record
    NCT06385925 · updated
  4. A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 to 99
    • All sexes
    Sponsor
    Erasca, Inc.
    Recruiting in
    Houston · Tyler
    Registry record
    NCT06983743 · updated
  5. A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    Astellas Pharma Global Development, Inc.
    Recruiting in
    Austin · Houston · Irving · and 1 more U.S. location
    Registry record
    NCT07488676 · updated
  6. A Study to Assess Safety and Efficacy of SOT109 in Patients With Advanced Unresectable or Metastatic Colorectal Cancer

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    SOTIO Biotech a.s.
    Recruiting in
    Houston
    Registry record
    NCT07693751 · updated
  7. Minimal Residual Disease Assessment in Patients With Colorectal Cancer, the MiRDA-C Study

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT04739072 · updated
  8. Preoperative Y-90 Radioembolization for Tumor Control and Future Liver Remnant Hypertrophy in Patients With Colorectal Liver Metastases

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT05195710 · updated
  9. Identifying Underserved Individuals inTexas With Hereditary Cancer Risk Using Mobile Mammography Units and Telegenetics.

    • No phase
    • Ages 18 and older
    • Female participants
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT05649072 · updated
  10. A Study to Evaluate the Safety, Pharmacokinetics, and Anti-Tumor Activity of VVD-133214 as Monotherapy and in Combination in Participants With Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Vividion Therapeutics, Inc.
    Recruiting in
    Houston · San Antonio
    Registry record
    NCT06004245 · updated
  11. A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Pliant Therapeutics, Inc.
    Recruiting in
    Austin · Fort Worth · Houston · and 1 more U.S. location
    Registry record
    NCT06270706 · updated
  12. Precision-MRD: Prospective Observational Study of Biomarker-directed Systemic Therapy for Colorectal Cancer Patients With Minimal Residual Disease

    • Observational
    • Ages 18 and older
    • All sexes
    Sponsor
    M.D. Anderson Cancer Center
    Recruiting in
    Houston
    Registry record
    NCT06878131 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Texas on ClinicalTrials.gov.

Ask about studies in Texas

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call